Application of Gastroscopy Based on Nano Carbon in the Remedy of Chronic Pulmonary Heart Disease Caused by Helicobacter Pylori
| Autor: | Lingqun Lu, Ningning Xing, Shirong Dong, Fei Jin, Peixia Lu, Liying Ping, Jin Li |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Helicobacter pylori infection Materials science Biomedical Engineering Bioengineering 02 engineering and technology Gastroenterology Helicobacter Infections Pulmonary heart disease Pulmonary Heart Disease Internal medicine Gastroscopy 0202 electrical engineering electronic engineering information engineering medicine Humans General Materials Science Helicobacter pylori biology Chronic pulmonary heart disease Respiratory disease 020206 networking & telecommunications Nano carbon General Chemistry Condensed Matter Physics medicine.disease biology.organism_classification Carbon Gastritis Right heart 020201 artificial intelligence & image processing medicine.symptom |
| Zdroj: | Journal of Nanoscience and Nanotechnology. 21:1127-1134 |
| ISSN: | 1533-4880 |
| DOI: | 10.1166/jnn.2021.18701 |
| Popis: | Chronic pulmonary heart disease is a common respiratory disease. Helicobacter pylori infection can lead to the occurrence of chronic pulmonary heart disease. However, most drugs for chronic pulmonary heart disease caused by helicobacter pylori are lack of tissue specificity. At the same time, due to the blocked blood circulation in the ischemic area, the distribution of drugs in the ischemic area is often not ideal. The gastroscope technology of nano carbon can make the drug release in the focus as much as possible, and can achieve the goal of targeted treatment. This paper mainly studies the application of the gastroscope technology based on nano carbon in the remedy of chronic pulmonary heart disease caused by helicobacter pylori. After 8 weeks of treatment, the indexes of right heart function in the two groups: TAPSE and RVMPI were better than before treatment, and the improvement degree in the remedy group was more obvious than that in the control group (P < 0.05). The improvement degree of E/A and PASP was not statistically significant, the difference between the two groups was not significant (P > 0.05). In addition, the gastroscope of nano carbon can also reduce UA and TG in blood. The overall response rate was 93.75% in the remedy group, which was higher than that in the control group (P < 0.05). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|